Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Navasa

Showing results (161-170 of 167) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 167 results.
Gastroenterology|October 1, 1996
Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitisM Navasa, A Follo, J M Llovet, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 9, 2010
Combined liver-kidney transplantation in patients with cirrhosis and chronic kidney diseaseM E Baccaro, M N Pépin, M Guevara, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 30, 2007
Gene transduction of an active mutant of akt exerts cytoprotection and reduces graft injury after liver transplantationM Morales-Ruiz, C Fondevila, J Muñoz-Luque, et al.
Hepatology (Baltimore, Md.)|June 10, 1998
Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic powerJ M Llovet, J Bruix, J Fuster, et al.
Clinical Immunology (Orlando, Fla.)|August 5, 2014
Should IFN-γ, IL-17 and IL-2 be considered predictive biomarkers of acute rejection in liver and kidney transplant? Results of a multicentric studyO Millán, L Rafael-Valdivia, D San Segundo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 6, 2012
Efficacy and safety of maribavir dosed at 100 mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, double-blind, multicenter controlled trialD J Winston, F Saliba, E Blumberg, et al.
Transplantation Proceedings|September 25, 2007
Gastrointestinal complications in liver transplant recipients: MITOS studyJ I Herrero, S Benlloch, A Bernardos, et al.
Pageof 17

Showing results (161-170 of 167) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
Gastroenterology|October 1, 1996
Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitisM Navasa, A Follo, J M Llovet, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 9, 2010
Combined liver-kidney transplantation in patients with cirrhosis and chronic kidney diseaseM E Baccaro, M N Pépin, M Guevara, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 30, 2007
Gene transduction of an active mutant of akt exerts cytoprotection and reduces graft injury after liver transplantationM Morales-Ruiz, C Fondevila, J Muñoz-Luque, et al.
Hepatology (Baltimore, Md.)|June 10, 1998
Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic powerJ M Llovet, J Bruix, J Fuster, et al.
Clinical Immunology (Orlando, Fla.)|August 5, 2014
Should IFN-γ, IL-17 and IL-2 be considered predictive biomarkers of acute rejection in liver and kidney transplant? Results of a multicentric studyO Millán, L Rafael-Valdivia, D San Segundo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 6, 2012
Efficacy and safety of maribavir dosed at 100 mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, double-blind, multicenter controlled trialD J Winston, F Saliba, E Blumberg, et al.
Transplantation Proceedings|September 25, 2007
Gastrointestinal complications in liver transplant recipients: MITOS studyJ I Herrero, S Benlloch, A Bernardos, et al.
Pageof 17